Joint hypermobility syndrome is a risk factor trait for anxiety disorders: A 15-year follow-up cohort study

General Hospital Psychiatry

Volumn 33, Issue 4, 2011, Pages 363-370

  Bulbena, Antoni ^a,b   Gago, Jordi ^c   Pailhez, Guillem ^a,b   Sperry, Lili ^d   Fullana, Miquel A ^a,b   Vilarroya, Oscar ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Centre de Salut de Sant Pere de Riudebitlles   (Spain)

^d Barcelona Biomedical Research Park   (Spain)

Author keywords

Anxiety disorders; Epidemiology; Joint hypermobility; Panic disorder; Social phobia

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADOLESCENT; ADULT; AGED; AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FOLLOW UP; HUMAN; INCIDENCE; JOINT HYPERMOBILITY; MAJOR CLINICAL STUDY; MENTAL DISEASE; PANIC; PHOBIA; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; SOCIAL PHOBIA; SPAIN;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDERS; COHORT STUDIES; EPIDEMIOLOGIC STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; JOINT INSTABILITY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 79960276507     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2011.03.004     Document Type: Article

References (37)

1. Berrios G. Anxiety disorders: a conceptual history. J Affect Disord 1999, 56:83-94.
2. Somers J.M., Goldner E.M., Waraich P., Hsu L. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatry 2006, 51:100-113.
3. Rotés J., Argany A. La laxitud articular como factor de alteraciones del aparato locomotor. Rev Esp Reumatol 1957, 1:59-62.
4. Beighton P., Solomon L., Soskolne C. Articular mobility in an African population. Ann Rheum Dis 1973, 32:413-418.
5. Beighton P., Grahame R., Bird H. Hypermobility of joints 1999, Springer, London.
6. Bulbena A., Duro J.C., Mateo A., Porta M., Vallejo J. Joint hypermobility syndrome and anxiety disorders. Lancet 1988, 2:694.
7. Bulbena A., Duro J.C., Porta M., et al. Anxiety disorders in the joint hypermobility syndrome. Psychiatry Res 1993, 46:59-68.
8. Martin-Santos R., Bulbena A., Porta M., Gago J., Molina L., Duro J.C. Association between joint hypermobility syndrome and panic disorder. Am J Psychiatry 1998, 155:1578-1583.
9. Gago J. Estudio de prevalencias y asociación de hiperlaxitud articular y trastornos ansioso fóbicos en población rural 1992, Universitat Autónoma Barcelona, Barcelona.
10. Bulbena A., Gago J., Martín-Santos R., Porta M., Dasquens J., Berrios G.E. Anxiety disorder and joint laxity: a definitive link. Neurol Psychiatry Brain Res 2004, 11:137-140.
11. Gratacos M., Nadal M., Martin-Santos R., et al. A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 2001, 106:367-379.
12. Hollox E.J., Armour J.A. No evidence for DNA copy number change associated with the DUP25 cytogenetic phenotype. Eur J Hum Genet 2003, 11:911-912.
13. Rubio G., Lopez-Ibor J.J. What can be learnt from the natural history of anxiety disorders. Eur Psychiatry 2007, 22:80-86.
14. First M.B., Spitzer R.L., Gibbon M.W.J. Entrevista clínica estructurada para los trastornos del eje I del dsm-IV. Versión clínica 1999, Masson, Barcelona.
15. Bulbena A., Duro J.C., Porta M., Faus S., Vallescar R., Martin-Santos R. Clinical assessment of hypermobility of joints: assembling criteria. J Rheumatol 1992, 19:115-122.
16. Grahame R., Bird H.A., Child A. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 2000, 27:1777-1779.
17. Goldberg D., Williams P. A user's guide to the general health questionnaire 1988, Nfer-nelson, Windsor.
18. Lobo A., Perez-Echeverria M.J., Artal J. Validity of the scaled version of the General Health Questionnaire (GHQ-28) in a Spanish population. Psychol Med 1986, 16:135-140.
19. Goldberg D., Williams P. Cuestionario de salud general GHQ. Versiones en lengua española validadas por Antonio Lobo y Pedro Enrique Muñoz 1996, Masson, Barcelona.
20. Mcnally R.J. Anxiety sensitivity and panic disorder. Biol Psychiatry 2002, 52:938-946.
21. Sandin B., Chorot P., Mcnally R.J. Anxiety sensitivity index: normative data and its differentiation from trait anxiety. Behav Res Ther 2001, 39:213-219.
22. Spielberger C.D., Gorsuch R.L., Lushene R.E. Cuestionario de ansiedad estado-rasgo. Manual 1986, Tea Ediciones, Madrid.
23. Bulbena A., Agullo A., Pailhez G., et al. Is joint hypermobility related to anxiety in a non-clinical population also?. Psychosomatics 2004, 45:432-437.
24. Bobes J., Badia X., Luque A., Garcia M., Gonzalez M.P., Dal-re R. Validation of the Spanish version of the Liebowitz social anxiety scale, social anxiety and distress scale and Sheehan disability inventory for the evaluation of social phobia. Med Clin (Barc) 1999, 112:530-538.
25. Heimberg R.G., Horner K.J., Juster H.R., et al. Psychometric properties of the Liebowitz social anxiety scale. Psychol Med 1999, 29:199-212.
26. Bulbena A., Gago J., Sperry L., Berge D. The relationship between frequency and intensity of fears and a collagen condition. Depress Anxiety 2006, 23:412-417.
27. Wells K.B., Golding J.M., Burnam M.A. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988, 145:976-981.
28. Harter M., Reuter K., Weisser B., Schretzmann B., Aschenbrenner A., Bengel J. A descriptive study of psychiatric disorders and psychosocial burden in rehabilitation patients with musculoskeletal diseases. Arch Phys Med Rehabil 2002, 83:461-468.
29. Gazit Y., Nahir A.M., Grahame R., Jacob G. Dysautonomia in the joint hypermobility syndrome. Am J Med 2003, 115:33-40.
30. Bulbena A., Pailhez G., Gago J. "Connective tissue" between panic disorder and dysautonomia. Am J Med 2004, 116:783.
31. Hakim A.J., Grahame R. Joint hypermobility. Best Pract Res Clin Rheumatol 2003, 17:989-1004.
32. Hulley S.B., Cummings S.R., Browner W.S., Grady D.G., Hearst N., Newman T.B. Designing clinical research 2001, Lippincott Williams, Filadelfia.
33. Alonso J., Angermeyer M.C., Bernert S., et al. Psychotropic drug utilization in Europe: results from the European study of the epidemiology of mental disorders (ESEMED) project. Acta Psychiatr Scand 2004, (Suppl):55-64.
34. Bovasso G. The long-term treatment outcomes of depression and anxiety comorbid with substance abuse. J Behav Health Serv Res 2001, 28:42-57.
35. Cornelius J.R., Fabrega H., Cornelius M.D., et al. Racial effects on the clinical presentation of alcoholics at a psychiatric hospital. Compr Psychiatry 1996, 37:102-108.
36. Neeleman J. The relativity of relative risks: disadvantage or opportunity?. Br J Psychiatry 2003, 182:101-102.
37. Bulbena A., Sperry L., Anguiano N., Pailhez G., Gago J. Joint hypermobility in schizophrenia: a potential marker for co-morbid anxiety. Open Psychiatr 2007, 1:31-33.